Nevin John

22PUBLICATIONS
139CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Clinical neuropsychologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|Jun 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Apr 26, 2026
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.

|Apr 01, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

|Feb 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple Sclerosis.

Nevin A John, Yingtong Li, Floriana De Angelis

Pageof 4

Frequent Collaborators

8 joint publications

Anneke van der Walt

6 joint publications

Floriana De Angelis

6 joint publications

Tomas Kalincik

6 joint publications

Izanne Roos